1800 202 8726
Drug monitoring

Tests and Monitoring — While on Cetuximab

Cetuximab treatment involves regular blood tests and checks from the first infusion onwards. Knowing what each test is looking for — and what an abnormal result triggers — helps you stay on top of your treatment and know when to call your team.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026

  • Blood tests before most infusions — Electrolytes, especially magnesium, are checked regularly because cetuximab commonly lowers them.
  • First infusion monitored most closely — The risk of an infusion reaction is highest with dose one, so it is given more slowly with closer observation.
  • Skin graded at every visit — The rash cetuximab causes is scored each visit so your team can decide whether to continue, pause or adjust your dose.
  • Response scans at planned intervals — CT or PET-CT scans are scheduled at set points in your treatment, not at every infusion.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a medical oncologist

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Cetuximab requires blood tests before most infusions to watch for low magnesium, which the drug commonly causes. Your skin is also assessed at every visit, because EGFR-related rash is graded to guide decisions about whether treatment continues. The first infusion needs the closest observation for reactions.

What tests will you have, and what does each one check?

  1. Electrolyte blood test (magnesium, potassium, calcium)

    This is the monitoring most specific to cetuximab. The drug commonly lowers magnesium in the blood, and potassium and calcium can also fall. Your team checks these before most infusions. A low magnesium result usually means replacement is given through a drip before your next infusion. If your magnesium stays very low despite replacement, your team may pause treatment while levels recover. Tell your team about muscle cramps, tingling, or an irregular heartbeat between visits — these can be signs that your electrolytes need checking sooner.

  2. Full blood count

    Cetuximab is not a chemotherapy drug and does not usually cause the sharp falls in blood cells that chemotherapy does. Your team will still check your red cells, white cells and platelets before infusions. A falling red cell count can cause increasing tiredness. If yours drops significantly, your team will decide whether a rest from treatment or another approach is needed.

  3. Liver function tests

    Your liver is occasionally affected by cetuximab. Enzyme levels are checked at baseline and at intervals during treatment. A mild rise often settles without any change to your treatment. A significant or rising result will prompt your team to pause and investigate before continuing.

  4. Monitoring during each infusion

    Your blood pressure, heart rate and oxygen level are checked throughout every infusion. The risk of a serious reaction — flushing, difficulty breathing, or a sudden drop in blood pressure — is highest with the first dose. Your team gives you antihistamine medication before the infusion and gives the first dose more slowly for this reason. A mild reaction can often be managed by slowing the drip. A severe reaction means cetuximab is stopped and not restarted.

  5. Skin and nail assessment at every visit

    An acneiform rash on the face, scalp and upper body is one of the most common effects of cetuximab. Your team grades it at each visit. Mild to moderate rash is managed with moisturisers, sunscreen and sometimes a short antibiotic course, and treatment continues. A severe rash means cetuximab is paused until the skin recovers. Nail changes and dry or cracked skin are also noted and treated.

How often will the blood tests happen?

Blood tests happen before most infusions. Cetuximab is usually given weekly or every two weeks, so your testing follows the same rhythm.

Electrolyte tests — especially for magnesium — may be checked more often early in treatment, when levels are most likely to fall. Your team may extend the interval once your results are stable.

If a result changes your plan, your team will contact you before your next visit. You will not be left to discover a problem on your own.

Not sure what this means for you?

Share your reports and a senior oncologist will explain your options in plain language — no obligation to start treatment.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

You do not have to work this out alone

A 45-minute consultation with a specialist who treats this every week.

Book Free Consultation Call 1800 202 8726

What happens if a test result is abnormal?

Most abnormal results during cetuximab treatment are managed without stopping treatment. Low magnesium is replaced. A rising liver enzyme result leads to a pause and a review, and in most cases treatment resumes once levels settle.

A severe skin reaction, a severe infusion reaction, or electrolyte levels that do not respond to replacement are the results most likely to lead to a longer pause or a permanent stop. Your team will explain the threshold that applies to your situation.

If a result concerns you, or you develop new symptoms between visits, call your team rather than waiting for the next scheduled appointment.

Did you know?

Low magnesium — hypomagnesemia — is one of the most frequently seen effects of cetuximab, affecting a substantial proportion of patients at some point during treatment.

It can develop gradually and without obvious symptoms until levels are significantly low. This is why the blood test is ordered before most infusions, not only when a patient reports a problem.

Source: ESMO Clinical Practice Guidelines for the management of EGFR inhibitor-related toxicities

Explore 100 more Gastrointestinal & Liver Targeted Medicines topics

All Gastrointestinal & Liver Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Do I need a blood test before every single infusion?

For most patients on cetuximab, electrolytes and a blood count are checked before each infusion, particularly in the early weeks of treatment. If your results have been consistently stable over several cycles, your oncologist may extend the interval between some tests. Ask your team what the schedule is for you specifically and whether it is likely to change over time. The schedule can also vary between centres, so confirm it directly with the team giving your treatment.

What does low magnesium feel like, and when should I call?

Mild low magnesium often causes no obvious symptoms at all, which is why blood testing — not how you feel — is the primary monitoring tool. When magnesium falls further, you may notice muscle cramps, weakness, tingling in the hands or feet, or a sensation that your heart is beating irregularly. Any of those symptoms between your scheduled blood tests is a reason to call your team on the same day rather than waiting for your next infusion.

If a rash appears between visits, what should I do?

A mild rash — some redness or spots that do not affect your daily life — can be noted and reported at your next scheduled visit. Keep the skin clean and moisturised, avoid direct sun, and use sunscreen every day as your team advises. If the rash becomes painful, blistering, covers a large area, affects your eyes, or stops you eating and drinking normally, call your team on the same day. Do not wait for your next appointment.

Can I see my own test results?

Yes. Your results belong to you and you can ask for a copy at any appointment. Having the numbers helps you track your magnesium and other levels over time. If you see a result outside the normal range and your team has not yet explained it, ask directly what it means for your next infusion rather than interpreting it from a reference range alone — the ranges on standard printouts are not always the ones that apply to patients on treatment.

Will I still need monitoring after my last infusion?

Some monitoring continues for a period after treatment ends. Magnesium levels can stay low for several weeks after the last dose, so your team may check them at least once after you finish. The skin rash typically resolves over several weeks once cetuximab is stopped. Your oncologist will tell you whether any blood tests are scheduled after your last infusion and what symptoms to watch for in the weeks that follow.

Call now Book free consultation